1 study found for:    18645164 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, United States Pharmacopeia (USP)

Indicates status has not been verified in more than two years